Our goal is to discover safe and effective drug treatments that will extend and improve the quality of lives of children with rare metabolic diseases.
Using tissue from patients, our drug discovery platform recreates complex pathophysiological pathways of rare diseases to identify novel targets and biomarkers and create superior therapeutics.
We believe that better models of human disease lead to identification of meaningful drug targets and discovery of successful new drug treatments.
Hemoshear works hard every day to advance critical research for challenging diseases. This February, our team is stepping out to support NORD’s Rare Disease Day Movement to bike, run or walk 7,000 Miles to help raise money for the 30 million Americans who need new treatments.